Faecal incontinence: common and treatable

Kamm, Michael A

doi:10.5694/j.1326-5377.2002.tb04280.x

Topics

The ability to remain continent is fundamental to our functioning as socially capable individuals. Loss of faecal continence leads to physical, psychological and social disability. Contrary to common belief, the condition is not confined to the disabled elderly. Rather, it affects people of all ages.

St Mark's Hospital, Harrow, London, UK.

Correspondence:

Competing interests:

Michael Kamm has acted as a consultant to Medtronic, Curon and Janssen Pharmaceuticals. His department has received financial support for research into the treatment of faecal incontinence from Medtronic and from SLA Pharma. He has an interest in the development of topical agents for the treatment of faecal incontinence.

1. Kalantar JS, Howell S, Talley NJ. Prevalence of faecal incontinence and associated risk factors. An underdiagnosed problem in the Australian community? Med J Aust 2001; 176: 54-57. <eMJA full text>
2. Vaizey CJ, Bartram CI, Kamm MA. Primary degeneration of the internal anal sphincter as a cause of passive faecal incontinence. Lancet 1997; 349: 612-615.
3. Sultan AH, Kamm MA, Hudson CN, et al. Anal-sphincter disruption during vaginal delivery. N Engl J Med 1993; 329: 1905-1911.
4. Al-Mufti R, McCarthy A, Fisk NM. Obstetricians' personal choice and mode of delivery. Lancet 1996; 347: 544.
5. Rintala R, Lindahl H, Marttinen E, Sariola H. Constipation is a major functional complication after internal sphincter-saving posterior sagittal anorectoplasty for high and intermediate anorectal malformations. J Pediatr Surg 1993; 28: 1054-1058.
6. Norton C, Kamm MA. Anal sphincter biofeedback and pelvic floor exercises for faecal incontinence in adults — a systematic review. Aliment Pharmacol Ther 2001; 15: 1147-1154.
7. Lund JN, Scholefield JH. A randomised, prospective, double-blind, placebo-controlled trial of glyceryl trinitrate ointment in treatment of anal fissure. Lancet 1997; 349: 11-14.
8. Carapeti EA, Kamm MA, Phillips RKS. Topical diltiazem and bethanechol decrease anal sphincter pressure and heal anal fissures without side effects. Dis Colon Rectum 2000; 43: 1359-1362.
9. Cheetham MJ, Kamm MA, Phillips RKS. Topical phenylephrine increases anal canal resting pressure in patients with faecal incontinence. Gut 2001; 48: 356-359.
10. Malouf AJ, Norton CS, Engel AF, et al. Long term results of overlapping anterior anal sphincter repair for obstetric trauma. Lancet 2000; 355: 260-265.
11. Vaizey CJ, Kamm MA, Gold DM, et al. Clinical, physiological, and radiological study of a new purpose-designed artificial bowel sphincter. Lancet 1998; 352: 105-109.
12. Malouf AJ, Vaizey CJ, Nicholls RJ, Kamm MA. Permanent sacral nerve stimulation for fecal incontinence. Ann Surg 2000; 232: 143-148.
13. Madoff RD, Rosen HR, Baeten CG, et al. Safety and efficacy of dynamic muscle plasty for anal incontinence: lessons from a prospective, multicenter trial. Gastroenterology 1999; 116: 549-556.

Online responses are no longer available. Please refer to our instructions for authors page for more information.